Influence of ALDH2 Genetic Polymorphisms on Aciclovir Pharmacokinetics following Oral Administration of Valaciclovir in Japanese End-stage Renal Disease Patients

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-10-25

著者

• NAGASHIMA Satoru

  Shitoro Clinic

• HARA Katsutoshi

  Clinical Pharmacology Department, GlaxoSmithKline K.K.

• SUYAMA Kazuaki

  Clinical Research Department, GlaxoSmithKline K.K.

• ITOH Hiroshi

  Biomedical Data Sciences Department, GlaxoSmithKline K.K.

• Suyama Kazuaki

  Clinical Research Department Glaxosmithkline K.k.

• Hara Katsutoshi

  Clinical Pharmacology Department Glaxosmithkline K.k.

• Itoh Hiroshi

  Biomedical Data Sciences Department Glaxosmithkline K.k.

関連論文

• Prediction of Pharmacokinetics of Antibiotics in Patients with End-Stage Renal Disease(Biopharmacy)
• Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease
• Influence of ALDH2 Genetic Polymorphisms on Aciclovir Pharmacokinetics following Oral Administration of Valaciclovir in Japanese End-stage Renal Disease Patients
• Pharmacokinetic and Pharmacodynamic Properties of Intravenous Darbepoetin Alfa (KRN321) in Japanese Hemodialysis Patients

スポンサーリンク